METTL3 and neoplasm: LINC02253 stabilizes KRT18 mRNA and upregulates KRT18 expression by promoting the recruitment of METTL3 to KRT18 mRNA, activating the MAPK/ERK signaling pathway, and promoting tumor growth and GC cell migration and invasion (54).